Tegoprazan for planned surgery patients under general anesthesia
Treatments studied
This trial tests whether a stomach-acid-reducing drug (tegoprazan) helps prevent complications during planned surgeries under general anesthesia. It is for adults aged 20–69 with a non-emergency surgery and a BMI under 35.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning a surgery that requires general anesthesia (medicine to make you sleep).
- You are between 20 and 69 years old.
- Your overall health is classified as ASA I, II, or III (healthy to stable chronic illness).
- Your surgery is not an emergency.
- Your body mass index (BMI) is less than 35.
- You have no history of drug abuse or dependence, and no known allergy to anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
This study tests a stomach-protecting medicine called tegoprazan for people who have had a stroke and are starting antiplatelet therapy. It aims to prevent stomach complications like ulcers or bleeding.
This trial tests if giving pantoprazole before surgery can reduce nausea and vomiting after gynecologic procedures. It may help patients who are having gynecologic surgery under general anesthesia.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
Hear when a new General Anesthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.